Envafolimab combined with lenvatinib and albumin-bound paclitaxel in previously treated advanced gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: a prospective, phase II, multi-cohort trial

Abstract Background This single-center, open-label, exploratory trial aimed to investigate the efficacy and safety of envafolimab combined with lenvatinib and chemotherapy in previous treated advanced G/GEJ adenocarcinoma. Methods Eligible patients with HER2-negative, microsatellite stable (MSS) adv...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zhao Xiaoying, Feng Wanjing, Geng Qirong, Huang Mingzhu, Zhang Zhe, Chen Jinsi, Sheng Xuedan, Zhu Xiaodong, Guo Weijian
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Springer 2026-04-01
Schriftenreihe:	Cancer Immunology, Immunotherapy
Schlagworte:	Gastric/gastroesophageal junction Albumin-bound paclitaxel Envafolimab
Online-Zugang:	https://doi.org/10.1007/s00262-026-04373-4
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!